MAGNETOLITH® ULTRA+ | EMTT
The STORZ MEDICAL MAGNETOLITH® Ultra+ represents an advancement in Extracorporeal Magnetotransduction Therapy (EMTT) for the regeneration and rehabilitation of musculoskeletal disorders. Building upon the capabilities of the original MAGNETOLITH®, the Ultra+ model offers enhanced features designed to improve treatment efficacy and user experience.
Benefits Over the Original MAGNETOLITH®:
The MAGNETOLITH® Ultra+ model’s advanced features, such as higher oscillation frequency and deeper tissue penetration, suggest improved treatment outcomes and enhanced user convenience.
The MAGNETOLITH® system for EMTT® is a rewarding investment that DOES NOT require any special maintenance, is low-cost to run, and provides clinicians a maximum return on their investment.
Why Choose STORZ MEDICAL:
Innovative Leadership: STORZ MEDICAL is renowned for pioneering non-invasive medical technologies and setting new standards across various medical disciplines.
Proven Efficacy: Their products have a well-established track record in urology and orthopedics and have been successfully adapted for other medical fields, demonstrating reliability and effectiveness.
Why Purchase from Kinas Medical:
Trusted Partnership:
As a family-owned and operated company, KINAS MEDICAL TECHNOLOGIES is a trusted distributor of STORZ MEDICAL products, offering personalized customer service and tailored shockwave therapy and EMTT solutions.
Comprehensive Support: They provide in-depth training, ongoing support, and a range of accessories to ensure that healthcare providers can effectively utilize their equipment to enhance patient care.
The MAGNETOLITH® Ultra+ offers advanced features that enhance treatment efficacy and user experience. Choosing STORZ MEDICAL ensures access to innovative and reliable medical technology, and partnering with KINAS MEDICAL provides personalized support and comprehensive solutions tailored to your practice’s needs.
- Advanced Technology: Utilizes high-energy magnetic pulses for non-invasive treatment of chronic musculoskeletal conditions, including lower back pain, sports injuries, degenerative joint disorders, and osteoarthritis.
- High Oscillation Frequency: Operates within a frequency range of 100 to 300 kHz, allowing for deeper tissue penetration up to 18 cm, which is more effective than traditional electromagnetic devices and technology, such as pulsed electromagnetic field therapy (PEMF) or others.
- User-Friendly Design: Features an integrated touch display to adjust energy levels, frequency, and pulse rate easily. The water-cooled applicator ensures continuous performance without overheating, and the flexible holding arm enables “touch-free” treatment, reducing clinician fatigue and providing convenient treatment through closing.
- Non-invasive, easy to use offering high patient comfort
- No reported side effects
- 9 energy levels, adjustable frequency up to 10 pulses per second
- High oscillating frequency with deep penetration
- HANDS & TOUCH-FREE treatment with the holding arm
- Clinicians suffer less from treatment fatigue
- Patients can remain dressed
- Short treatment times (5 to 15 min. depending on the indication)
- Great team player! Use EMTT technology with radial and focused shockwave for a more comprehensive and effective result!
Hands and Touch-Free
Powerful Anti-Inflammatory
No Downtime
The MAGNETOLITH® ultra+ in Action
Learn More About the MAGNETOLITH® Ultra+
Reach out to us today to schedule a free demonstration.
EMTT® Clinical Evidence
References of systematic reviews of significant therapeutic effects with STORZ MEDICAL EMTT® devices:
- Lennart Gerdesmeyer – https://pubmed.ncbi.nlm.nih.gov/39457582/
- Andre Krath. et al., Journal of Orthopaedics, 14(3):410-415, 2017. DOI: Electromagnetic transduction therapy in non-specific low back pain: A randomized clinical trial
- Klüter, T. et al., Electromagnetic Biology and Medicine, 37(4):175-183, 2018. DOI: Electromagnetic transduction therapy and shockwave therapy in 86 patients with rotator cuff tendinopathy: A prospective randomized controlled trial.
- Gerdesmeyer, L. et al., The Journal for Foot and Ankle Surgery, 56(5):964-967, 2017. DOI: Electromagnetic Transduction Therapy for Achilles Tendinopathy: A Preliminary Report on a New Technology.
- Klüter, T. et al., Journal of Orthopedic Research and Therapy: JORT-1113, 2018. DOI: Electromagnetic Transduction Therapy in Patients with Chronic Aseptic Osteitis Pubis
- Ringeisen, M., Ludger Gerdesmeyer., Presentation at the annual congress of the umbrella association osteology (DVO), March 2018, Dresden. Therapy of traumatic/mechanical bone marrow edema with electro magnetotransduction therapy [in German].
- Teresa Paolucci1 et al., Journal of Pain Res. 13: 1385–1400, 2020; DOI: 10.2147/JPR.S231778
Electromagnetic Field Therapy: A Rehabilitative Perspective in the Management of Musculoskeletal Pain – A Systematic Review, Journal of Pain Research
Additional resources (web links):
- DIGEMTT – German-speaking International Society for Extracorporeal Magnetotransductions Therapy (for healthcare professionals only)
- EMTT – STORZ Information Homepage (Information for healthcare professionals and patients)
EMTT: A Case Study | Dr. Sharon Reynolds kyle, DC
Dr. Sharon Reynolds-Kyle is a skilled shockwave clinician and has made waves in the shockwave education space with her work across the globe, both independently and also with The Academy of Shockwave Excellence. She recently attended the ISMST Conference in Amsterdam (June 2024) and presented multiple studies to the shockwave community, including this one below on EMTT. We are proud to call her a member of our Kinas Medical family, and hope to see more of her shared knowledge!
